Clinuvel Pharmaceuticals Ltd (CUV) — Free Cash Flow Generation Index
Clinuvel Pharmaceuticals Ltd (CUV) has a Free Cash Flow Generation Index of 0.99x as of December 2025. Free cash flow of AU$12.38 Million represents 1% of operating cash flow (AU$12.52 Million). Read Clinuvel Pharmaceuticals Ltd debt and liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Clinuvel Pharmaceuticals Ltd Free Cash Flow Generation Index (2017–2025)
Historical FCF Generation Index trend for Clinuvel Pharmaceuticals Ltd across 9 annual periods. Explore reinvestment intensity of Clinuvel Pharmaceuticals Ltd to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Clinuvel Pharmaceuticals Ltd (2017–2025)
Year-by-year Free Cash Flow Generation Index for Clinuvel Pharmaceuticals Ltd. For the full company profile including market capitalisation, see Clinuvel Pharmaceuticals Ltd market cap and net worth.
| Year | FCG Index | Free Cash Flow (AUD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.99x | AU$40.80 Million | AU$41.10 Million | AU$298.57K | ▲ +16.9% |
| 2024 | 0.85x | AU$31.48 Million | AU$37.05 Million | AU$5.58 Million | ▼ -12.6% |
| 2023 | 0.97x | AU$35.88 Million | AU$36.91 Million | AU$1.03 Million | ▼ -1.7% |
| 2022 | 0.99x | AU$39.44 Million | AU$39.87 Million | AU$434.44K | ▲ +3.5% |
| 2021 | 0.96x | AU$18.41 Million | AU$19.26 Million | AU$854.33K | ▲ +2.0% |
| 2020 | 0.94x | AU$13.30 Million | AU$14.19 Million | AU$888.83K | ▼ -4.9% |
| 2019 | 0.99x | AU$18.20 Million | AU$18.46 Million | AU$257.62K | ▼ -0.8% |
| 2018 | 0.99x | AU$11.62 Million | AU$11.69 Million | AU$75.12K | ▲ +0.0% |
| 2017 | 0.99x | AU$9.85 Million | AU$9.92 Million | AU$67.48K | — |